BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6546632)

  • 1. [Aseptic necrosis of the femur head as a complication of intensive cytostatic, glucocorticoid and radiation therapy of lymphogranulomatosis].
    Semenov II; Gershanovich ML; Artiushkin AV
    Vopr Onkol; 1984; 30(2):35-9. PubMed ID: 6546632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
    Sciascia R; Albisinni U; Ammendolia I; Barbieri E; Tondi L
    Radiol Med; 1989 Apr; 77(4):336-41. PubMed ID: 2471231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
    Virgolini L; De Maglio A
    Ital J Orthop Traumatol; 1992; 18(4):543-6. PubMed ID: 1345650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
    Murray F; Daly PA; Freyne PJ
    Ir J Med Sci; 1983 Jul; 152(7):286-8. PubMed ID: 6688611
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aseptic necrosis of the head of long tubular bones in patients with lymphogranulomatosis].
    Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP; Semenov II
    Vopr Onkol; 1988; 34(12):1448-54. PubMed ID: 3218148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
    Casini M; Pianezze G; Fabris P; Cemin S; Coser P
    Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W; Drzewoski J; Robak T; Krykowski E
    Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
    [No Abstract]   [Full Text] [Related]  

  • 10. Retroperitoneal fibrosis following treatment for Hodgkin's disease.
    Chao N; Levine J; Horning SJ
    J Clin Oncol; 1987 Feb; 5(2):231-2. PubMed ID: 3100728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 13. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 14. [The late sequelae of the combined treatment of lymphogranulomatosis patients].
    Miasnikov AA
    Ter Arkh; 1990; 62(7):135-7. PubMed ID: 2251653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of childhood Hodgkin's disease.
    Ekert H
    J Clin Oncol; 1991 Mar; 9(3):528-9. PubMed ID: 1999723
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.